![Dave Ahern](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dave Ahern
Vorstandsvorsitzender bei Coalesce Product Development Ltd.
Ursprung des Netzwerks ersten Grades von Dave Ahern
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Coalesce Product Development Ltd.
![]() Coalesce Product Development Ltd. Medical SpecialtiesHealth Technology Part of Novartis AG, Coalesce Product Development Ltd. is a British company that develops inhalation devices. The company is based in Cambridge, UK. The company was founded in 2009 by Dave Ahern, who has been the CEO since 2009. Coalesce Product Development was acquired by Sandoz AG on March 14, 2022.
2
| Subsidiary | Medical Specialties | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Dave Ahern
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ImCyse SA
![]() ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
Docpharma NV
![]() Docpharma NV Pharmaceuticals: MajorHealth Technology Docpharma NV provides generic drugs. These drugs are used to treat infections, hypertension, allergies, bronchial and asthmatic problems, gastric and vomiting discomforts, pain and depression. It was founded by Leon Van Rompay in 1999 and is headquartered in Heverlee, Belgium. | Pharmaceuticals: Major | Chief Executive Officer | |
Uteron Pharma SA
![]() Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Uteron Pharma SA is engaged in the research and development of controlled release devices. The firms products Levosert and Diafert provide pharmaceutical solutions for women's health. The company was founded by Stijn van Rompay in 2010 and is headquartered in Grâce-Hollogne, Belgium. | Electronic Equipment/Instruments | Chief Executive Officer | |
Alter Pharma Group NV
![]() Alter Pharma Group NV Pharmaceuticals: MajorHealth Technology Alter Pharma Group NV manufactures and distributes pharmaceutical products. The company was founded in 2006 and is headquartered in Anderlecht, Belgium. | Pharmaceuticals: Major | Founder | |
HYLORIS PHARMACEUTICALS SA | Pharmaceuticals: Major | Founder | |
University of Antwerp | College/University | Graduate Degree | |
EXO Biologics SA
![]() EXO Biologics SA BiotechnologyHealth Technology EXO Biologics SA operates as a Belgian biotechnology company. The company is based in Liege, Belgium. The company was founded in 2019. Hugues Wallemacq has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Hyloris Developments SA
![]() Hyloris Developments SA Pharmaceuticals: MajorHealth Technology Hyloris Developments SA is a Belgian pharmaceutical company that manufactures and sells pharmaceutical products. The private company is based in Liege, Belgium. The company was founded in 2013. The CEO is Stijn van Rompay. | Pharmaceuticals: Major | Chief Executive Officer | |
Innovata Ltd.
![]() Innovata Ltd. Pharmaceuticals: MajorHealth Technology Innovata Ltd. researches and develops pharmaceutical and medical products. It develops pulmonary products for the treatment of respiratory disorders and other serious diseases. The company was founded on July 20,1987 and is headquartered in Nottingham, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Leicester | College/University | Doctorate Degree | |
VECTURA GROUP | Pharmaceuticals: Major | Corporate Officer/Principal | |
GlaxoSmithKline Biologicals NV
![]() GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. | Biotechnology | Corporate Officer/Principal | |
Quadrant Healthcare Plc
![]() Quadrant Healthcare Plc Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Quadrant Healthcare Plc is a British company that researches, develops, and formulates drugs. The company is based in Cambridge, UK. Quadrant Healthcare was acquired by Elan Europe Ltd. on January 11, 2001 for $69.60 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BP PLC | Integrated Oil | Corporate Officer/Principal | |
British Sugar Plc
![]() British Sugar Plc Agricultural Commodities/MillingProcess Industries British Sugar Plc manufactures and distributes sugar. The company supplies cereals, confectionary, drinks, ice-cream & other dairy products, pharmaceutical & nutraceutical products, condiments, sauces, and canned goods. It was founded in 1936 and is headquartered in Peterborough, UK. | Agricultural Commodities/Milling | Corporate Officer/Principal |
Statistik
International
Belgien | 10 |
Vereinigtes Königreich | 7 |
Sektoral
Health Technology | 11 |
Consumer Services | 3 |
Electronic Technology | 2 |
Energy Minerals | 2 |
Process Industries | 2 |
Operativ
Director/Board Member | 7 |
Corporate Officer/Principal | 7 |
Chief Executive Officer | 6 |
Founder | 3 |
Director of Finance/CFO | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Stijn van Rompay | 9 |
Colin Clive Dalton | 9 |
- Börse
- Insiders
- Dave Ahern
- Unternehmensverbindungen